
  
    
      
        Background_NNP
        Aging_NNP has_VBZ been_VBN associated_VBN with_IN decreased_VBD function_NN and_CC
        exercise_NN performance_NN [_NN 1_CD 2_CD ]_NN ._. Decreased_NNP exercise_NN
        performance_NN has_VBZ been_VBN related_VBN to_TO decreased_VBD oxidative_JJ
        capacity_NN [_NN 3_CD 4_CD ]_NN and_CC decreased_VBD muscle_NN mass_NN [_NN 4_CD ]_NN ._. Vascular_NNP
        alterations_NNS in_IN structure_NN and_CC function_VB due_JJ to_TO aging_VBG could_MD
        also_RB contribute_VB to_TO decreased_VBD exercise_NN performance_NN through_IN
        impaired_VBN blood_NN flow_NN [_NN 5_CD ]_NN ._. Decreased_NNP capillary_JJ density_NN [_NN 6_CD
        ]_NN and_CC a_DT thickening_VBG of_IN vascular_NN walls_NNS [_NN 7_CD ]_NN are_VBP present_JJ with_IN
        aging_VBG ._.
        Vascular_NNP function_NN is_VBZ altered_VBN with_IN aging_VBG and_CC may_MD
        influence_VB muscle_NN blood_NN flow_NN and_CC exercise_NN performance_NN ._.
        Altered_NNP vascular_NN function_NN in_IN older_JJR individuals_NNS is_VBZ evidenced_VBN
        as_IN impaired_VBN endothelial_NN function_NN [_NN 8_CD 9_CD 10_CD ]_NN ,_, an_DT altered_VBN
        ratio_NN of_IN endothelin_NN receptors_NNS [_NN 11_CD ]_NN ,_, and_CC /_NN or_CC altered_VBN
        reactivity_NN of_IN the_DT smooth_JJ muscle_NN to_TO sympathetic_JJ activity_NN [_NN 7_CD
        12_CD ]_NN ._. Reduced_NNP endothelial_NN function_NN is_VBZ related_VBN to_TO impaired_VBN
        formation_NN and_CC decreased_VBD activation_NN of_IN nitric_JJ oxide_NN [_NN 13_CD 14_CD
        ]_NN and_CC is_VBZ particularly_RB prominent_JJ in_IN older_JJR subjects_NNS with_IN
        evidence_NN of_IN cardiovascular_JJ disease_NN [_NN 15_CD ]_NN ,_, diabetes_NN [_NN 16_CD ]_NN
        ,_, or_CC obesity_NN [_NN 17_CD ]_NN ._. Interestingly_RB ,_, aging_NN does_VBZ not_RB appear_VB
        to_TO effect_VB endothelium_NN independent_JJ vasodilation_NN [_NN 10_CD 14_CD ]_NN
        ._.
        These_DT structural_JJ and_CC functional_JJ alterations_NNS in_IN the_DT
        vascular_NN system_NN may_MD explain_VB age_NN associated_VBN reductions_NNS in_IN
        muscle_NN blood_NN flow_NN ._. Decreased_NNP leg_NN blood_NN flow_NN and_CC vascular_NN
        conductance_NN are_VBP present_JJ in_IN elderly_JJ compared_VBN to_TO young_JJ
        subjects_NNS during_IN whole_JJ body_NN exercise_NN [_NN 18_CD ]_NN and_CC in_IN response_NN
        to_TO reactive_JJ hyperemia_NN [_NN 13_CD ]_NN ._. Decreased_NNP basal_NN limb_NN blood_NN
        flow_NN was_VBD related_VBN to_TO increased_VBN vasoconstriction_NN in_IN the_DT
        elderly_JJ compared_VBN to_TO younger_JJR individuals_NNS [_NN 19_CD ]_NN ._. However_RB ,_,
        not_RB all_DT studies_NNS have_VBP shown_VBN age_NN related_VBD changes_NNS in_IN blood_NN
        flow_NN ._. Resting_NNP blood_NN flow_NN and_CC post_NN exercise_NN hyperemia_NN was_VBD
        similar_JJ in_IN elderly_JJ compared_VBN to_TO younger_JJR subjects_NNS [_NN 20_CD ]_NN ._.
        Blood_NNP flow_NN responses_NNS to_TO single_VB limb_NN exercise_NN have_VBP also_RB been_VBN
        preserved_VBN in_IN older_JJR individuals_NNS [_NN 21_CD 22_CD ]_NN ._. Discrepancies_NNS in_IN
        aging_VBG effects_NNS on_IN muscle_NN blood_NN flow_NN may_MD be_VB due_JJ to_TO the_DT use_NN of_IN
        active_JJ [_NN 18_CD ]_NN or_CC inactive_JJ subjects_NNS [_NN 13_CD ]_NN ._. In_IN addition_NN ,_, it_PRP
        is_VBZ not_RB clear_JJ whether_IN the_DT age_NN related_VBD changes_NNS in_IN blood_NN flow_NN
        were_VBD a_DT result_NN of_IN reduced_VBN cardiac_JJ output_NN during_IN whole_JJ body_NN
        exercise_NN or_CC reduced_VBN local_JJ vascular_NN capacity_NN ._. These_DT
        inconsistent_JJ findings_NNS of_IN reduced_VBN blood_NN flow_NN in_IN older_JJR
        subjects_NNS suggest_VBP that_IN other_JJ age-associated_JJ factors_NNS are_VBP
        involved_VBN ._.
        Physical_JJ activity_NN status_NN influences_VBZ vascular_NN function_NN
        and_CC may_MD explain_VB alterations_NNS in_IN muscle_NN blood_NN flow_NN ._. Exercise_NNP
        training_NN increases_NNS cardiac_JJ output_NN during_IN exercise_NN and_CC
        increases_NNS skeletal_NN muscle_NN blood_NN flow_NN in_IN response_NN to_TO
        reactive_JJ hyperemia_NN [_NN 23_CD ]_NN ._. Arterial_NNP diameters_NNS [_NN 19_CD 24_CD ]_NN ,_,
        capillary_JJ density_NN [_NN 5_CD 25_CD ]_NN ,_, vascular_NN reactivity_NN [_NN 26_CD 27_CD ]_NN
        ,_, and_CC endothelial_NN function_NN [_NN 9_CD 28_CD ]_NN are_VBP improved_VBN with_IN
        training_NN and_CC reduced_VBN with_IN inactivity_NN ._.
        The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO determine_VB if_IN aging_VBG had_VBN
        an_DT influence_NN on_IN muscle_NN blood_NN flow_NN independent_JJ of_IN habitual_NN
        physical_JJ activity_NN levels_NNS ._. Specifically_RB ,_, we_PRP examined_VBD single_JJ
        leg_NN blood_NN flow_NN in_IN response_NN to_TO reactive_JJ hyperemia_NN with_IN
        active_JJ and_CC inactive_JJ older_JJR subjects_NNS in_IN comparison_NN to_TO active_JJ
        and_CC inactive_JJ young_JJ subjects_NNS ._. We_PRP tested_VBD the_DT hypothesis_NNS that_IN
        aging_VBG would_MD result_VB in_IN reductions_NNS in_IN limb_NN blood_NN flow_NN
        independent_JJ of_IN physical_JJ activity_NN ._.
      
      
        Methods_NNP
        
          Subjects_NNP
          Thirty-five_CD subjects_NNS participated_VBD in_IN the_DT study_NN between_IN
          the_DT ages_NNS of_IN 20_CD and_CC 81_CD years_NNS ._. Subjects_NNP were_VBD divided_VBN into_IN
          four_CD groups_NNS ,_, Young_NNP Active_JJ (_( YA_NNP )_) (_( mean_VB =_SYM 27_CD years_NNS ,_, n_NN =_SYM 10_CD )_) ,_,
          Young_NNP Inactive_NNP (_( YI_NNP )_) (_( mean_VB =_SYM 21_CD years_NNS ,_, n_NN =_SYM 9_CD )_) ,_, Older_JJR
          Active_JJ (_( OA_NNP )_) (_( mean_VB =_SYM 70_CD years_NNS ,_, n_NN =_SYM 8_CD )_) ,_, and_CC Older_JJR Inactive_NNP
          (_( OI_NNP )_) (_( mean_VB =_SYM 77_CD years_NNS ,_, n_NN =_SYM 8_CD )_) ._. Subjects_NNP were_VBD classified_VBN
          as_IN active_JJ if_IN they_PRP reported_VBD participating_VBG in_IN 40_CD minutes_NNS of_IN
          moderate_JJ intensity_NN exercise_NN at_IN least_JJS three_CD times_NNS a_DT week_NN
          for_IN the_DT previous_JJ six_CD months_NNS ._. The_DT subjects_NNS classified_VBN as_IN
          inactive_JJ reported_VBD no_DT regular_JJ physical_JJ exercise_NN ._. All_DT
          subjects_NNS reported_VBD no_DT history_NN of_IN disease_NN or_CC other_JJ
          confounding_VBG factors_NNS ._. The_DT physical_JJ characteristics_NNS of_IN the_DT
          subjects_NNS are_VBP shown_VBN in_IN Table_NNP 1_CD ._. The_DT study_NN was_VBD conducted_VBN
          with_IN the_DT approval_NN of_IN the_DT Institutional_NNP Review_NNP Board_NNP at_IN
          the_DT University_NNP of_IN Georgia_NNP ._.
        
        
          Protocol_NNP
          Subjects_NNP rested_VBD in_IN a_DT supine_NN position_NN for_IN 10_CD -_: 15_CD minutes_NNS
          prior_RB to_TO testing_NN ._. Resting_NNP blood_NN pressure_NN was_VBD obtained_VBN ._.
          Ischemia_NNP was_VBD induced_VBN in_IN the_DT lower_JJR limb_NN by_IN inflation_NN of_IN a_DT
          blood_NN pressure_NN cuff_VB 100_CD mmHg_NN above_IN systolic_JJ blood_NN
          pressure_NN measured_VBN in_IN the_DT arm_NN ._. Blood_NNP flow_NN was_VBD measured_VBN at_IN
          rest_NN and_CC in_IN response_NN to_TO 10_CD minutes_NNS of_IN cuff_VB ischemia_NN ._. Cuff_NNP
          placement_NN was_VBD distal_NN to_TO the_DT Doppler_NNP probe_NN and_CC was_VBD placed_VBN
          directly_RB above_IN the_DT knee_NN ._. Cuff_NNP inflation_NN and_CC deflation_NN was_VBD
          rapid_JJ (_( 1_CD -_: 2_CD seconds_NNS )_) using_VBG a_DT rapid_JJ inflation_NN device_NN (_( D_NNP ._. E_NNP ._.
          Hokanson_NNP ,_, Inc_NNP )_) ._. Blood_NNP pressure_NN was_VBD measured_VBN continuously_RB
          to_TO measure_VB changes_NNS during_IN the_DT test_NN as_IN a_DT result_NN of_IN cuff_VB
          ischemia_NN (_( Finapres_NNP ,_, Ohmeda_NNP )_) ._.
        
        
          Blood_NNP Flow_NNP
          Blood_NNP flow_NN was_VBD measured_VBN continuously_RB in_IN the_DT common_JJ
          femoral_NN artery_NN using_VBG quantitative_JJ Doppler_NNP ultrasound_NN
          (_( General_NNP Electric_NNP LogiQ_NNP 400_CD CL_NNP )_) with_IN a_DT frequency_NN of_IN 6_CD
          MHz_NNP ._. Pulsed_NNP Doppler_NNP ultrasound_NN was_VBD recorded_VBN using_VBG an_DT
          insonation_NN angle_NN of_IN 45_CD °_NN -_: 60_CD °_NN ._. The_DT velocity_NN gate_NN was_VBD set_VBN to_TO
          include_VB the_DT entire_JJ arterial_NN diameter_NN ._. Doppler_NNP waveforms_NNS
          were_VBD analyzed_VBN to_TO determine_VB the_DT time_NN average_NN maximum_NN
          velocity_NN by_IN General_NNP Electric_NNP 's_POS advanced_VBD vascular_NN program_NN
          software_NN ._. B-_NNP mode_NN images_NNS were_VBD measured_VBN during_IN diastole_NN to_TO
          determine_VB vessel_NN diameter_NN ._. Peak_NNP systolic_JJ blood_NN flow_NN was_VBD
          calculated_VBN as_IN the_DT product_NN of_IN the_DT vessel_NN cross_NN sectional_JJ
          area_NN and_CC time_VB average_JJ maximal_NN velocity_NN ._. Blood_NNP flow_NN
          response_NN to_TO 10_CD minutes_NNS of_IN cuff_VB ischemia_NN was_VBD an_DT index_NN of_IN
          peak_NN blood_NN flow_NN response_NN [_NN 27_CD ]_NN ._. Conductance_NNP was_VBD
          calculated_VBN by_IN dividing_VBG the_DT maximal_NN blood_NN flow_NN by_IN the_DT mean_JJ
          arterial_NN pressure_NN (_( MAP_NNP )_) ._. Half_NN time_NN to_TO recovery_NN was_VBD
          determined_VBN as_IN the_DT time_NN where_WRB blood_NN flow_NN dropped_VBD to_TO one_CD
          half_PDT the_DT magnitudes_NNS between_IN maximum_NN flow_NN and_CC resting_VBG flow_NN
          values_NNS ._.
        
        
          Near_IN Infrared_JJ Spectroscopy_NNP (_( NIRS_NNP )_)
          Muscle_NNP oxygen_NN delivery_NN was_VBD determined_VBN by_IN the_DT half_JJ time_NN
          of_IN recovery_NN of_IN oxygen_NN saturation_NN after_IN cuff_VB ischemia_NN [_NN 29_CD
          ]_NN ._. Oxygen_NNP saturation_NN was_VBD measured_VBN using_VBG a_DT continuous_JJ
          light_JJ source_NN ,_, dual_JJ wavelength_NN NIRS_NNP device_NN (_( Runman_NNP CW_NNP 2000_CD ,_,
          NIM_NNP ,_, Inc_NNP ._. ,_, Philadelphia_NNP )_) ._. The_DT probe_NN contained_VBD two_CD small_JJ
          tungsten_NN filament_NN lamps_NNS ,_, 6_CD cm_NN apart_RB which_WDT emit_NN white_JJ
          light_NN ,_, and_CC two_CD photo_NN detectors_NNS with_IN filters_NNS for_IN 760_CD and_CC
          850_CD nm_NN light_JJ located_VBN between_IN the_DT lights_NNS ._. Brief_NN flashes_NNS of_IN
          light_JJ migrated_JJ through_IN the_DT tissue_NN and_CC were_VBD collected_VBN by_IN
          the_DT detectors_NNS at_IN wavelengths_NNS set_VBN by_IN two_CD optical_JJ filters_NNS ._.
          Oxyhemoglobin_NNP has_VBZ a_DT greater_JJR absorbance_NN at_IN 850_CD nm_NN compared_VBN
          to_TO 760_CD nm_NN ,_, with_IN deoxyhemoglobin_NN absorbing_VBG more_JJR at_IN 760_CD
          than_IN 850_CD nm_NN ._. The_DT difference_NN between_IN the_DT signal_NN at_IN 760_CD and_CC
          850_CD nm_NN was_VBD used_VBN as_IN the_DT index_NN of_IN relative_JJ oxygen_NN
          saturation_NN ._.
        
        
          Leg_NNP volume_NN
          Leg_NNP volume_NN measurements_NNS were_VBD determined_VBN by_IN Doppler_NNP
          ultrasound_NN measurements_NNS of_IN fat_JJ thickness_NN and_CC by_IN
          circumference_NN measurements_NNS of_IN the_DT lower_JJR leg_NN ._. Subcutaneous_NNP
          fat_NN was_VBD determined_VBN by_IN B-_NNP mode_NN images_NNS of_IN the_DT thickness_NN
          between_IN skin_NN and_CC muscle_NN fascia_NN ._. Measurements_NNP were_VBD
          attained_VBN every_DT three_CD centimeters_NNS over_IN the_DT Medial_NNP
          Gastrocnemius_NNP and_CC over_IN the_DT Anterior_NNP Tibialis_NNP muscles_NNS ._.
          Based_VBN on_IN the_DT circumference_NN and_CC fat_JJ measurements_NNS total_JJ
          leg_NN ,_, fat_JJ ,_, and_CC lean_JJ area_NN volume_NN ,_, were_VBD calculated_VBN ._.
        
        
          Analysis_NNP
          An_DT analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) (_( SPSS_NNP version_NN 10_CD ._. 0_CD )_)
          was_VBD conducted_VBN to_TO test_VB for_IN aging_VBG and_CC activity_NN effects_NNS as_RB
          well_RB as_IN to_TO test_VB for_IN differences_NNS by_IN group_NN ._. Data_NNP was_VBD
          analyzed_VBN to_TO verify_VB normality_NN and_CC to_TO test_VB for_IN any_DT
          outliers_NNS ._. Analyses_NNS were_VBD conducted_VBN at_IN a_DT significance_NN level_NN
          of_IN 0_CD ._. 05_CD ._.
        
      
      
        Results_NNS
        
          Baseline_NNP data_NNS
          Subjects_NNP in_IN the_DT older_JJR groups_NNS had_VBD higher_JJR resting_VBG
          systolic_JJ blood_NN pressure_NN (_( p_NN =_SYM 0_CD ._. 003_CD )_) ,_, diastolic_JJ blood_NN
          pressure_NN (_( p_NN =_SYM 0_CD ._. 012_CD )_) ,_, MAP_NNP (_( p_NN =_SYM 0_CD ._. 002_CD )_) ,_, and_CC heart_NN rate_NN (_( p_NN
          =_SYM 0_CD ._. 013_CD )_) compared_VBN to_TO the_DT young_JJ groups_NNS (_( Table_NNP 1_LS )_) ._. There_EX
          were_VBD no_DT differences_NNS in_IN blood_NN pressure_NN or_CC heart_NN rate_NN with_IN
          physical_JJ activity_NN level_NN ._. Lean_VB leg_NN volume_NN was_VBD 15_CD %_NN lower_JJR in_IN
          the_DT older_JJR subjects_NNS compared_VBN to_TO the_DT younger_JJR subjects_NNS (_( p_NN =_SYM
          0_CD ._. 049_CD )_) ,_, despite_IN a_DT lack_NN of_IN difference_NN in_IN height_NN ,_, or_CC body_NN
          weight_NN ._. When_WRB comparing_VBG the_DT four_CD groups_NNS separately_RB ,_, MAP_NNP
          was_VBD higher_JJR in_IN the_DT older_JJR inactive_JJ compared_VBN to_TO young_JJ
          inactive_JJ group_NN (_( p_NN =_SYM 0_CD ._. 015_CD )_) ._. The_DT older_JJR inactive_JJ group_NN had_VBD
          a_DT higher_JJR systolic_JJ blood_NN pressure_NN compared_VBN to_TO the_DT young_JJ
          inactive_JJ group_NN that_WDT approached_VBD significance_NN (_( p_NN =_SYM 0_CD ._. 084_CD )_) ._.
          Resting_NNP heart_NN rate_NN was_VBD lower_JJR in_IN the_DT young_JJ active_JJ group_NN
          compared_VBN to_TO both_DT of_IN the_DT older_JJR groups_NNS (_( F_NN (_( 3_CD ,_, 32_CD )_) =_SYM 4_CD ._. 561_CD ,_, p_NN
          =_SYM 0_CD ._. 010_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 243_CD )_) ._. Resting_NNP femoral_NN artery_NN diameter_NN as_RB
          well_RB as_IN resting_VBG normalized_JJ blood_NN flow_NN and_CC resting_VBG
          conductance_NN were_VBD not_RB different_JJ on_IN aging_VBG or_CC activity_NN
          effects_NNS or_CC on_IN differences_NNS between_IN groups_NNS (_( Table_NNP 2_LS )_) ._.
        
        
          Cuff_NNP ischemia_NN
          The_DT cuff_VB occlusion_NN protocol_NN was_VBD not_RB associated_VBN with_IN
          any_DT changes_NNS in_IN heart_NN rate_NN or_CC blood_NN pressure_NN ._. There_EX was_VBD a_DT
          greater_JJR time_NN averaged_VBD maximal_NN blood_NN flow_NN in_IN the_DT younger_JJR
          groups_NNS (_( 2180_CD ±_NN 590_CD ml_NN /_NN min_NN vs_NNS ._. 1700_CD ±_NN 570_CD ml_NN /_NN min_NN ,_, for_IN
          young_JJ versus_CC older_JJR ,_, respectively_RB ;_: F_NN (_( 1_CD ,_, 35_CD )_) =_SYM 5_CD ._. 986_CD ,_, p_NN =_SYM
          0_CD ._. 020_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 154_CD )_) and_CC active_JJ groups_NNS (_( 2220_CD ±_NN 640_CD ml_NN /_NN min_NN
          versus_CC 1680_CD ±_NN 470_CD ml_NN /_NN min_NN ,_, for_IN active_JJ versus_CC inactive_JJ ,_,
          respectively_RB ;_: F_NN (_( 1_CD ,_, 35_CD )_) =_SYM 8_CD ._. 015_CD ,_, p_NN =_SYM 0_CD ._. 008_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 195_CD )_) ._.
          The_DT maximal_NN blood_NN flow_NN was_VBD different_JJ between_IN groups_NNS
          (_( F_NN (_( 3_CD ,_, 35_CD )_) =_SYM 5_CD ._. 764_CD ,_, p_NN =_SYM 0_CD ._. 003_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 358_CD )_) with_IN the_DT young_JJ
          active_JJ group_NN having_VBG higher_JJR blood_NN flow_NN than_IN the_DT young_JJ
          inactive_JJ group_NN (_( p_NN =_SYM 0_CD ._. 047_CD )_) and_CC the_DT old_JJ inactive_JJ group_NN (_( p_NN
          =_SYM 0_CD ._. 002_CD )_) (_( Table_NNP 2_LS )_) ._.
          When_WRB maximal_NN blood_NN flow_NN was_VBD normalized_JJ to_TO estimated_VBN
          lean_JJ muscle_NN mass_NN there_EX was_VBD a_DT higher_JJR blood_NN flow_NN in_IN the_DT
          active_JJ compared_VBN to_TO inactive_JJ groups_NNS (_( F_NN (_( 1_CD ,_, 33_CD )_) =_SYM 15_CD ._. 690_CD ,_, p_NN
          <_NN 0_CD ._. 001_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 356_CD )_) (_( Figure_NN 1_LS )_) with_IN no_DT significant_JJ
          age_NN effects_NNS ._. Maximal_NNP blood_NN flow_NN when_WRB normalized_JJ to_TO lean_VB
          muscle_NN mass_NN was_VBD different_JJ between_IN the_DT four_CD groups_NNS
          (_( F_NN (_( 3_CD ,_, 33_CD )_) =_SYM 5_CD ._. 784_CD ,_, p_NN =_SYM 0_CD ._. 003_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 374_CD )_) with_IN the_DT young_JJ
          active_JJ group_NN having_VBG greater_JJR blood_NN flow_NN than_IN the_DT young_JJ
          inactive_JJ (_( p_NN =_SYM 0_CD ._. 031_CD )_) and_CC the_DT old_JJ inactive_JJ groups_NNS (_( p_NN =_SYM
          0_CD ._. 005_CD )_) (_( Table_NNP 2_LS )_) ._. Conductance_NNP of_IN normalized_JJ maximal_NN blood_NN
          flow_NN was_VBD greater_JJR in_IN the_DT young_JJ (_( F_NN (_( 1_CD ,_, 33_CD )_) =_SYM 10_CD ._. 513_CD ,_, p_NN =_SYM
          0_CD ._. 003_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 253_CD )_) and_CC the_DT active_JJ (_( F_NN (_( 1_CD ,_, 33_CD )_) =_SYM 11_CD ._. 011_CD ,_, p_NN =_SYM
          0_CD ._. 002_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 262_CD )_) groups_NNS (_( Figure_NN 2_LS )_) ._. Conductance_NNP of_IN
          normalized_JJ maximal_NN blood_NN flow_NN was_VBD higher_JJR in_IN the_DT young_JJ
          active_JJ compared_VBN to_TO old_JJ inactive_JJ group_NN (_( p_NN <_NN 0_CD ._. 001_CD )_)
          (_( Table_NNP 2_LS )_) ._.
          Maximal_NNP blood_NN flow_NN had_VBD a_DT slower_JJR return_NN to_TO resting_VBG
          values_NNS (_( half_JJ time_NN to_TO recovery_NN )_) in_IN the_DT older_JJR groups_NNS
          compared_VBN to_TO the_DT younger_JJR groups_NNS (_( F_NN (_( 1_CD ,_, 35_CD )_) =_SYM 4_CD ._. 684_CD ,_, p_NN =_SYM
          0_CD ._. 038_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 124_CD )_) (_( Figure_NN 3_LS )_) ._. The_DT half_JJ time_NN to_TO recovery_NN
          of_IN blood_NN flow_NN was_VBD not_RB different_JJ between_IN the_DT active_JJ and_CC
          inactive_JJ groups_NNS ._. Half_NN time_NN to_TO recovery_NN approached_VBD
          significance_NN between_IN the_DT four_CD groups_NNS (_( F_NN (_( 3_CD ,_, 35_CD )_) =_SYM 2_CD ._. 406_CD ,_, p_NN
          =_SYM 0_CD ._. 086_CD ,_, Η_NN 2_CD =_SYM 0_CD ._. 189_CD )_) (_( Table_NNP 2_LS )_) ._. The_DT half_JJ time_NN of_IN recovery_NN
          of_IN oxygen_NN saturation_NN measured_VBN with_IN NIRS_NNP was_VBD not_RB different_JJ
          between_IN groups_NNS ,_, although_IN the_DT older_JJR inactive_JJ group_NN
          appeared_VBD to_TO have_VB slower_JJR recovery_NN values_NNS (_( Table_NNP 2_LS )_) ._.
        
      
      
        Discussion_NNP
        The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO determine_VB if_IN aging_VBG or_CC
        activity_NN had_VBD an_DT effect_NN on_IN peripheral_JJ blood_NN flow_NN ._. The_DT
        primary_JJ finding_NN of_IN this_DT study_NN was_VBD that_DT peak_NN blood_NN flow_NN
        capacity_NN was_VBD related_VBN to_TO activity_NN level_NN while_IN there_EX was_VBD no_DT
        age_NN effect_NN independent_JJ of_IN activity_NN level_NN ._. Our_PRP$ results_NNS are_VBP
        consistent_JJ with_IN others_NNS which_WDT have_VBP reported_VBN no_DT age-related_JJ
        changes_NNS in_IN maximal_NN flow_NN capacity_NN after_IN exercise_NN [_NN 20_CD 21_CD 22_CD
        ]_NN ._. A_DT strength_NN of_IN this_DT study_NN was_VBD that_DT maximal_NN blood_NN flow_NN
        capacity_NN was_VBD normalized_JJ to_TO estimated_VBN lean_JJ muscle_NN mass_NN ,_, to_TO
        correct_VB for_IN age-related_JJ decreases_NNS in_IN muscle_NN mass_NN [_NN 2_CD ]_NN
        ._.
        We_PRP did_VBD not_RB find_VB age_NN related_VBD changes_NNS in_IN resting_VBG blood_NN
        flow_NN or_CC resting_VBG diameter_NN ._. In_IN contrast_NN ,_, other_JJ studies_NNS have_VBP
        found_VBN age-related_JJ changes_NNS in_IN resting_VBG blood_NN flow_NN which_WDT have_VBP
        been_VBN attributed_VBN to_TO increases_NNS in_IN sympathetic_JJ tone_NN [_NN 19_CD 30_CD ]_NN
        ._. Aging_NNP has_VBZ been_VBN associated_VBN with_IN reduced_VBN blood_NN flow_NN and_CC
        vascular_NN conductance_NN during_IN whole_JJ body_NN exercise_NN [_NN 18_CD ]_NN ._.
        The_DT reduction_NN in_IN blood_NN flow_NN and_CC conductance_NN have_VBP been_VBN
        related_VBN to_TO alterations_NNS in_IN cardiac_JJ output_NN and_CC blood_NN volume_NN
        due_JJ to_TO aging_VBG [_NN 23_CD ]_NN ._. Several_JJ of_IN our_PRP$ resting_VBG blood_NN flow_NN
        variables_NNS approached_VBD significance_NN (_( p_NN values_NNS below_IN 0_CD ._. 10_CD )_)
        indicating_VBG that_IN our_PRP$ results_NNS may_MD have_VB been_VBN significant_JJ with_IN
        a_DT larger_JJR sample_NN size_NN ._. However_RB ,_, the_DT significance_NN of_IN age_NN
        related_VBD changes_NNS in_IN resting_VBG blood_NN flow_NN are_VBP unclear_JJ other_JJ
        than_IN serving_VBG as_IN a_DT marker_NN for_IN altered_VBN sympathetic_JJ tone_NN ;_:
        especially_RB if_IN maximal_NN blood_NN flow_NN capacity_NN is_VBZ not_RB changed_VBN
        with_IN age_NN ._.
        We_PRP found_VBD that_IN our_PRP$ active_JJ subjects_NNS had_VBD greater_JJR maximal_NN
        blood_NN flow_NN capacity_NN (_( ≈_NN 30_CD %_NN )_) than_IN our_PRP$ inactive_JJ subjects_NNS
        regardless_RB of_IN age_NN ._. Consistent_NNP with_IN our_PRP$ results_NNS Martin_NNP et_CC
        al_NN ._. [_NN 31_CD ]_NN reported_VBD a_DT greater_JJR vasodilatory_NN capacity_NN in_IN
        trained_VBN than_IN untrained_JJ subjects_NNS independent_JJ of_IN age_NN ._.
        Inactivity_NNP has_VBZ been_VBN associated_VBN with_IN impaired_VBN efficiency_NN of_IN
        peripheral_JJ oxygen_NN extraction_NN [_NN 32_CD ]_NN and_CC reduced_VBN blood_NN flow_NN
        after_IN cuff_VB ischemia_NN [_NN 33_CD ]_NN ._. Conversely_RB ,_, exercise_NN training_NN
        results_NNS in_IN greater_JJR maximal_NN flow_NN capacity_NN [_NN 31_CD 34_CD ]_NN ._.
        Regular_JJ aerobic_JJ exercise_NN also_RB prevents_VBZ the_DT age-associated_JJ
        loss_NN in_IN endothelium_NN dependent_JJ vasodilation_NN maintaining_VBG
        maximal_NN flow_NN capacity_NN [_NN 9_CD ]_NN ._. Our_PRP$ findings_NNS support_VBP previous_JJ
        research_NN that_DT maximal_NN flow_NN capacity_NN is_VBZ maintained_VBN by_IN
        aerobic_JJ exercise_NN and_CC is_VBZ independent_JJ of_IN age_NN ._.
        Because_IN blood_NN flow_NN is_VBZ dependent_JJ on_IN perfusion_NN pressure_NN ,_,
        blood_NN flow_NN data_NNS is_VBZ often_RB presented_VBN as_IN conductance_NN (_( flow_NN
        divided_VBN by_IN mean_NN arterial_NN pressure_NN )_) ._. This_DT is_VBZ important_JJ in_IN
        aging_VBG studies_NNS as_IN age_NN is_VBZ associated_VBN with_IN increases_NNS in_IN blood_NN
        pressure_NN [_NN 19_CD 30_CD ]_NN ._. We_PRP found_VBD that_DT maximal_NN conductance_NN was_VBD
        reduced_VBN in_IN our_PRP$ older_JJR subjects_NNS ,_, consistent_JJ with_IN a_DT higher_JJR
        mean_NN arterial_NN pressure_NN in_IN these_DT subjects_NNS ._. We_PRP also_RB found_VBD
        higher_JJR maximal_NN conductance_NN in_IN the_DT young_JJ active_JJ group_NN
        compared_VBN to_TO the_DT older_JJR inactive_JJ subjects_NNS ,_, again_RB explained_VBN by_IN
        differences_NNS in_IN mean_NN arterial_NN pressure_NN ._. Another_DT study_NN has_VBZ
        reported_VBN aging_VBG to_TO be_VB associated_VBN with_IN reduced_VBN conductance_NN [_NN
        18_CD ]_NN ._. However_RB ,_, it_PRP is_VBZ unclear_JJ how_WRB important_JJ differences_NNS in_IN
        maximal_NN conductance_NN between_IN groups_NNS is_VBZ when_WRB there_EX is_VBZ no_DT
        difference_NN in_IN maximal_NN blood_NN flow_NN ._. The_DT lack_NN of_IN difference_NN in_IN
        blood_NN flow_NN suggests_VBZ that_DT oxygen_NN delivery_NN is_VBZ not_RB compromised_VBN
        despite_IN the_DT reduced_VBN conductance_NN ._. It_PRP is_VBZ possible_JJ that_IN the_DT
        vascular_NN system_NN in_IN the_DT older_JJR subjects_NNS has_VBZ compensated_VBN for_IN
        the_DT higher_JJR mean_NN arterial_NN pressures_NNS ._.
        Consistent_NNP with_IN the_DT lack_NN of_IN age_NN differences_NNS in_IN maximal_NN
        blood_NN flow_NN ,_, we_PRP found_VBD no_DT age_NN differences_NNS in_IN oxygen_NN delivery_NN
        as_IN measured_VBN by_IN NIRS_NNP ._. Oxygen_NNP delivery_NN after_IN exercise_NN has_VBZ
        been_VBN found_VBN to_TO be_VB similar_JJ between_IN healthy_JJ active_JJ older_JJR and_CC
        younger_JJR subjects_NNS [_NN 35_CD ]_NN ._. It_PRP was_VBD expected_VBN ,_, however_RB ,_, that_DT
        oxygen_NN delivery_NN would_MD be_VB different_JJ between_IN the_DT active_JJ and_CC
        inactive_JJ individuals_NNS ._. The_DT older_JJR inactive_JJ did_VBD appear_VB to_TO have_VB
        prolonged_JJ oxygen_NN delivery_NN but_CC the_DT young_JJ inactive_JJ did_VBD not_RB ._.
        This_DT suggests_VBZ that_DT oxygen_NN delivery_NN may_MD be_VB more_RBR sensitive_JJ to_TO
        the_DT interaction_NN of_IN age_NN and_CC inactivity_NN ._. Future_JJ studies_NNS are_VBP
        needed_VBN to_TO clarify_VB the_DT influence_NN of_IN age_NN and_CC activity_NN level_NN
        on_IN oxygen_NN delivery_NN ._.
        An_DT interesting_JJ finding_NN in_IN this_DT study_NN was_VBD that_IN the_DT half_JJ
        time_NN to_TO recovery_NN of_IN blood_NN flow_NN was_VBD prolonged_JJ (_( ≈_NN 28_CD %_NN )_) in_IN the_DT
        older_JJR compared_VBN to_TO young_JJ subjects_NNS ,_, independent_JJ of_IN activity_NN
        status_NN ._. This_DT is_VBZ one_CD of_IN the_DT first_JJ studies_NNS to_TO our_PRP$ knowledge_NN
        that_WDT has_VBZ investigated_VBN blood_NN flow_NN recovery_NN kinetics_NNS in_IN these_DT
        populations_NNS ._. Slow_NNP recovery_NN of_IN blood_NN flow_NN has_VBZ been_VBN used_VBN as_IN
        an_DT index_NN of_IN reduced_VBN vascular_NN reactivity_NN in_IN coronary_JJ
        arteries_NNS [_NN 36_CD ]_NN ._. The_DT hyperemic_JJ response_NN to_TO ischemia_NN is_VBZ
        dependent_JJ on_IN the_DT presence_NN and_CC response_NN to_TO metabolic_JJ factors_NNS
        and_CC vasoactive_JJ substances_NNS such_JJ as_IN nitric_JJ oxide_NN and_CC
        adenosine_NN [_NN 37_CD ]_NN ._. The_DT prolonged_JJ recovery_NN of_IN blood_NN flow_NN in_IN
        our_PRP$ study_NN could_MD be_VB due_JJ to_TO either_CC a_DT greater_JJR buildup_NN of_IN
        metabolic_JJ factors_NNS /_NN vasoactive_JJ substances_NNS and_CC /_NN or_CC a_DT diminished_VBN
        ability_NN to_TO remove_VB them_PRP in_IN the_DT older_JJR subjects_NNS ._. This_DT study_NN ,_,
        however_RB ,_, was_VBD not_RB designed_VBN to_TO determine_VB the_DT mechanism_NN for_IN
        the_DT increased_VBN time_NN for_IN blood_NN flow_NN to_TO recover_VB ._. A_DT prolonged_JJ
        half_JJ time_NN to_TO recovery_NN has_VBZ been_VBN associated_VBN with_IN a_DT decreased_VBN
        nitric_JJ oxide_NN and_CC prostanoid_NN production_NN [_NN 8_CD ]_NN and_CC a_DT loss_NN of_IN
        endothelium_NN dependent_JJ vasodilation_NN [_NN 9_CD ]_NN ._. Reduced_NNP vascular_NN
        reactivity_NN is_VBZ associated_VBN with_IN many_JJ diseases_NNS that_WDT are_VBP
        associated_VBN with_IN aging_VBG [_NN 15_CD 16_CD 17_CD ]_NN ._. We_PRP did_VBD not_RB find_VB
        activity_NN effects_NNS on_IN half_JJ time_NN to_TO recovery_NN ._. This_DT finding_VBG
        contrasts_VBZ other_JJ previously_RB published_VBN studies_NNS which_WDT have_VBP
        shown_VBN decreased_VBN vascular_NN reactivity_NN in_IN individuals_NNS who_WP are_VBP
        required_VBN to_TO be_VB on_IN bed_NN rest_NN [_NN 26_CD 38_CD ]_NN and_CC in_IN individuals_NNS
        with_IN spinal_JJ cord_NN injuries_NNS [_NN 27_CD ]_NN ._. It_PRP is_VBZ possible_JJ that_IN the_DT
        differences_NNS in_IN activity_NN levels_NNS between_IN our_PRP$ groups_NNS in_IN this_DT
        study_NN were_VBD not_RB large_JJ enough_RB to_TO produce_VB the_DT same_JJ effects_NNS
        that_WDT are_VBP seen_VBN with_IN bed_NN rest_NN and_CC spinal_JJ cord_NN injury_NN ._.
        In_IN summary_NN ,_, we_PRP found_VBD that_DT maximal_NN blood_NN flow_NN capacity_NN
        was_VBD significantly_RB related_VBN to_TO activity_NN level_NN but_CC was_VBD not_RB
        related_VBN to_TO age_NN ._. Blood_NNP flow_NN calculated_VBN as_IN conductance_NN was_VBD
        related_VBN to_TO aging_VBG and_CC activity_NN ,_, consistent_JJ with_IN the_DT reduced_VBN
        blood_NN flow_NN in_IN the_DT inactive_JJ subjects_NNS and_CC the_DT higher_JJR blood_NN
        pressures_NNS in_IN the_DT older_JJR subjects_NNS ._. In_IN addition_NN ,_, the_DT older_JJR
        subjects_NNS had_VBD evidence_NN of_IN reduced_VBN vascular_NN reactivity_NN ,_, as_IN
        measured_VBN by_IN prolonged_JJ half_JJ time_NN to_TO recovery_NN ,_, independent_JJ of_IN
        activity_NN status_NN ._. The_DT prolonged_JJ half_JJ time_NN to_TO recovery_NN in_IN the_DT
        older_JJR subjects_NNS is_VBZ likely_RB related_VBN to_TO a_DT reduced_VBN vascular_NN
        reactivity_NN associated_VBN with_IN increased_VBN cardiovascular_JJ disease_NN
        risk_NN ._. Thus_RB ,_, maximal_NN flow_NN capacity_NN and_CC the_DT half_JJ time_NN to_TO
        recovery_NN of_IN blood_NN flow_NN are_VBP influenced_VBN by_IN different_JJ
        mechanisms_NNS in_IN young_JJ and_CC older_JJR active_JJ and_CC inactive_JJ
        subjects_NNS ._.
      
    
  
